Benitec Biopharma BNTC

$ 10.45 -3.24%

Annual report 2024
added 09-26-2024

Benitec Biopharma Balance Sheet 2011-2024 | BNTC

Annual Balance Sheet Benitec Biopharma

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-1.92 M	-3.25 M	-	-9.4 M	-15.7 M	-11.8 M	-13.4 M	-13.6 M	-16.7 M	-20.5 M	-28.6 M	-	-
Long Term Debt	-	284 K	559 K	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	284 K	275 K	252 K	213 K	192 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	213 K	-	35.3 K	26.9 K	13.4 K	-	-	-	-	-
Total Current Liabilities	4.92 M	3.98 M	2.53 M	1.37 M	1.14 M	-	-	-	-	-	-	-	-	-
Total Liabilities	4.96 M	4.26 M	3.09 M	1.37 M	1.35 M	2.64 M	1.91 M	891 K	786 K	1.26 M	1.55 M	872 K	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-190 M	-181 M	-148 M	-130 M	-117 M	-98.9 M	-108 M	-104 M	-98.1 M	-82.7 M	-101 M	-87.9 M	-	-
Total Assets	52.2 M	4.46 M	5.97 M	21.4 M	11.6 M	19.2 M	15.7 M	17.4 M	14.9 M	19.6 M	24 M	31.5 M	-	-
Cash and Cash Equivalents	50.9 M	2.48 M	4.06 M	19.8 M	9.8 M	15.7 M	-	-	-	-	-	-	-	-
Book Value	47.2 M	202 K	2.88 M	20 M	10.2 M	16.6 M	13.8 M	16.5 M	14.1 M	18.3 M	22.5 M	30.6 M	-	-
Total Shareholders Equity	47.2 M	202 K	2.88 M	20 M	10.2 M	16.6 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Benitec Biopharma

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	62 K	137 K	211 K	284 K	354 K	422 K	491 K	559 K	635 K	698 K	760 K	-	-	108 K	161 K	213 K	213 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	3.5 M	5.88 M	4.74 M	4.26 M	3.51 M	2.91 M	3.5 M	3.09 M	2.54 M	3.18 M	2.36 M	1.37 M	1.37 M	887 K	1.18 M	1.35 M	1.35 M	-	-	2.64 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-185 M	-181 M	-174 M	-168 M	-163 M	-159 M	-153 M	-148 M	-143 M	-140 M	-135 M	-130 M	-130 M	-122 M	-119 M	-117 M	-117 M	-	-	-109 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	15 M	21.4 M	27.1 M	4.46 M	8.22 M	11.9 M	18.1 M	5.97 M	10.1 M	14 M	17.8 M	21.4 M	21.4 M	15.5 M	8.92 M	11.6 M	11.6 M	-	-	19.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	14.1 M	20.4 M	25.9 M	2.49 M	6.56 M	10.6 M	16.5 M	4.06 M	8.63 M	12.3 M	15.7 M	19.8 M	19.8 M	14 M	7.45 M	14 M	7.45 M	13.8 M	16.6 M	15.7 M	-	-	-	11.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	11.5 M	15.5 M	22.3 M	202 K	4.71 M	8.99 M	14.6 M	2.88 M	7.52 M	10.8 M	15.5 M	20 M	20 M	14.6 M	7.74 M	10.2 M	10.2 M	-	-	16.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	11.5 M	15.5 M	22.3 M	202 K	4.71 M	8.99 M	14.6 M	2.88 M	7.52 M	10.8 M	15.5 M	20 M	15.5 M	14.6 M	14.6 M	14.6 M	7.74 M	15.3 M	17 M	16.6 M	-	-	-	13.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency